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Control of Differentiation in BC3H1
Muscle Cells
by Luis Glaser*t and Burton Wice*
BC3H1 is acell line that undergoes amusclelike pattern ofdifferentiation underthe appropriate conditions.
We have examined the control ofthe synthesis ofproteins characteristic ofdifferentiated muscle in these cells
as a function oftheir position in the cell cycle. We define two positions in the cell cycle where BC3H1 cells
can remain stably quiescent. Gid is a restriction point early in the GI portion ofthe cell cycle that permits
the synthesis ofmuscle-specific proteins and is probably identical to Go. The second restriction point, Glq,
occurs approximately 4hrlaterintheGI portion ofthecellcycle anddoes notpennitthesynthesis ofmuscle-
specific proteins. Movement ofthe cells from Gld toGlq occurs when fibroblast growth factor is added to the
cells and is reversed when this growth factor is removed. Repression ofthe synthesis ofmuscle-specific pro-
teins occurs whenfibroblastgrowth factor is added to cells in Gid. In the case ofthe muscle form ofcreatine
phosphokinase (M-CPK), the decline in the rate synthesis ofthisprotein is aconsequence ofa decreased level
ofits mRNA. Bycontrast, therepression ofa-actinsynthesis, aproteinsynthesizedonly in differentiated cells,
appears to becontrolled at the translational level. The effect offibroblast growth factor and other mitogens
in these cells require activation oftyrosine kinase(s), but the intracellular targets ofthese kinases are not
known. Studies byothers suggest thatactivation ofthe ras oncogene can mimic the action ofmitogenic poly-
peptides on these and other muscle cells. However, these observations do not prove that activation ofthe ras
protooncogene is directly responsible for the effect ofmitogenic polypeptides on these cells.
Introduction
The control of cell differentiation is one ofthe central
problems ofmodern biology. Studies ofmuscle differen-
tiation have been at the forefront ofthis field because of
the availability ofdefined (often cloned) cells that can be
induced to differentiate under controlled conditions in the
laboratory.
It isfrequently true that the study ofslightly abnormal
cells, in which the pathway ofdifferentiation hasbeen par-
tially altered, provides unique insights into the normal se-
quence of events. The BC3H1 cell line (1) is a nonfusing
muscle cell line that has been particularly useful in this
regard. These cells do not fuse, but under appropriate
conditions, differentiate. Differentiation is definedhere as
alarge increase in the rate ofsynthesis ofproteins charac-
teristic ofmature muscle such as M-CPK (1-4), vascular
smooth muscle a-actin (a-actin) (5,6), and the nicotinic
acetylcholine receptor(AChR)(1,7,8) (Fig. 1). The advan-
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tage ofthe BC3H1 cellline is thatthe differentiation pro-
cess can be reversed by the addition of serum or
well-characterizedmitogenic polypeptides such as fibro-
blastgrowth factor(FGF)(4,6,9-11)(Fig. 1). We summa-
rize here our current knowledge derived from work in a
number oflaboratories in addition to our own ofthis pro-
cess and speculate on the broader implications of this
work for our understanding of muscle differentiation.
Differentiation of BC3H1 Cells
Figure 2 provides agraphic description ofour current
knowledge of differentiation in BC3H1 cells. The ex-
perimental observations on which this is based are found
in the original publications (4,6,9) and will only be men-
tioned briefly. In Figure 2 we show the cell cycle of eu-
karyotic cells, and we identify two restriction points at
which cells can remain quiescent and viable, both in the
G1 portion ofthe cellcycle. GldisequivalenttoGo(12)and
represents arestrictionpointpermissive for cell differen-
tiation, whileGlq, 4 to 6hrfurtherin the GI phase ofthe
cell cycle, is nonpermissive for cell differentiation (6,9).
When exponentiallygrowing BC3H1 cells that are at a
cell density high enough to allow extensive cell-cell con-
tact are transferred from a medium containing high con-
centrations of serum to a medium containing low levelsGLASER AND WICE
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FIGURE 1. Relationship between cell growth and differentiation in BC3H1 cells. Logarithmically growing BC3H1 cells in 35-mm dishes were trans-
ferred from D-MEM containing 20% FCS to D-MEM containing 1% FCS on day 0. Cells were harvested at times indicated. (0) Cells in 1% FCS;
(0) cells to which 20% FCS was added on day 3; (A) cells to which FGF was added on day 3. Cell number was determined using aCoulter counter.
The rate ofM-CPK synthesis (B) was measured essentially as described (4,9). Briefly, cells were labeled for 1.5 hr with "S-methionine and CPK
was immunoprecipitated from cell homogenates. The muscle and brain isozymes were separated by SDS-gel electrophoresis. After fluorography
ofthe gels, the amount of"S-CPK wasquantitated by densitometry and normalized to the rate oftotalprotein synthesis. The rate ofisoactin syn-
thesis (C-E) was determined as described (6). Briefly, cells were labeled for 1 hr with 35S-methionine and the actins were purified from cell
homogenates using DNase I affinity chromatography. The 35S-actins were then subjected to isoelectric focusingto separatethe a-,fi-, andy-isoforms
or to SDS-gel electrophoresis to determine the amount of total "5S-actin. The amount of "5S-actin in the gels was quantitated as for M-CPK.
ofserum, they arrest in Gld and initiate a differentiation
program thatresults inthe accumulation ofhighlevels of
M-CPK (1-4), AChR (1,7,9,13), and a-actin (6), while the
rate ofsynthesis ofnonmuscle (3- andy-actin is decreased
(6)(Fig. 1). In the case ofM-CPKand a-actin, itis known
that their expression in differentiated cells requires the
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FIGURE 2. Differentiation and position in the cell cycle in BC3H1 cells.
The figure illustrates in diagramatic fashion the control of diffentia-
tion in BC3H1 cells and the induction ofc-fbs. Cells arrested early in
the GI portion ofthe cell cycle (Gld or Go) differentiate while cells ar-
rested laterinGI at GIq are quiescent but cannot differentiate. Move-
ment from Gld to Glq can be induced by addition of FGF and is
reversed upon removal of FGF. Transit from Gld to Glq is accompa-
niedby induction of a number ofproteins characteristic ofearly por-
tion ofGI, the figure illustrates the induction ofc-fos. Synthesis (+)
or lack of synthesis (-) of the indicated protein. AChR (?) indicates
that the effects of FGF on the synthesis of AChR has not been
reported for BC3H1 cells, although P-TGF has been reported to in-
hibit the cell surface expression of AChR in these cells (13).
synthesis of mRNAs absent in logarithmically growing
cells (5,14); hence, induction of differentiation involves
transcriptional control ofthese genes. The difference in
thelevel oftheseproteins betweengrowingand differen-
tiating cells can be several hundredfold (Fig. 1).
When high concentrations ofserum are added to differ-
entiated BC3H1 cells, the cells reinitiate growth (3-11).
Concomitantly, the synthesis ofmuscle-specific proteins
ceases (3-11), and the cells initiate the synthesis ofpro-
teins characteristic ofgrowing cells, for example P and y
actin (5,6) (Fig. 1). Serum is a complex mixture of
molecules, and it is impossible to ascertain whether the
effects ofserum on the differentiated phenotype are due
to a single effectormolecule orwhethermultiple compo-
nents are involved. As will be shown, the multiple com-
ponents are probably involved.
Since the inhibition ofthe differentiation program oc-
curswhencellgrowthresumes, itistemptingto examine
known mitogenic polypeptides for their ability to in-
fluence growth and differentiation in BC3H1 cells.
Lathrop etal. could showthateitherhighlypurifiedacidic
FGF (aFGF) orrelatively crude basic FGF (bFGF)when
added to differentiated BC3H1 cells blocked expression
ofM-CPK(4). However, the addition ofthesepolypeptides
to cells initially in Gld was not sufficient to initiate cell
growth (6,9). The P-transforming growth factor (P-TGF)
affects differentiation of BC3H1 cells similarly to FGF
(13). More recentobservations suggestthatin some sub-
populations orclone(s)ofBC3H1 cells, epidernalgrowth
factor(EGF)hasasimilareffectonthe differentiationpro-
gram as FGF but EGF allows differentiated BC3H1 cells
to reinitiate growth (15).
Avariety ofobservations indicate that addition ofFGF
to BC3H1 cells in Gld results in movement ofthese cells
from Gld to a newrestriction point Glq about 4 hr closer
to the G1-S boundary than Gld. These observations can
be summarized as follows: a) when stimulated to divide
by additionofserum, cells inGlq enterthe Sphase ofthe
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cell cycle 4 to 6 hr before cells in Gld (6,9); b) addition of
FGF to cells inGld results in arapid andtransient induc-
tion of the synthesis of the c-fos protooncogene charac-
teristic ofcells progressingfrom Gld(Go) to G1 (6); c) ad-
dition of FGF to cells in Gld results in significant
induction ofthe synthesis ofornithine decarboxylase(9),
which is characteristic of cells transiting through early
partsofG1 (16); and d)the transitofcellsfromGld toGlq
requires 4 to 6 hr of exposure to FGF (9), although it
seems likely that as soon as cells exit Gld they are no
longerpermissive for the synthesis ofdifferentiated pro-
teins.
The levels ofcontrol ofthe synthesis ofvarious proteins
associated with the differentiated phenotype appears to
be different (Table 1). When cells exit from Gld, synthe-
sis ofM-CPK mRNA ceases (6,10) (Fig. 3), the message
decays with a half-time of about 8 hr (independent of
whether cells are in Gld or not, (10), and there is a cor-
responding decline in the rate of M-CPK synthesis (9).
The rate ofa-actin synthesis also declines when cells exit
Gld (5,6); however, this rate ofsynthesis is not areflection
oflevels ofa-actin mRNA, which remain relatively high
(6)(Fig. 3, Table 1). This istruewhetherthe exitfromGld
is induced by addition ofFGF, which brings cells to Glq
(6), or by addition ofEGF or serum, which, in appropri-
ate EGF responsive clones, allows cells to continue
through the cell cycle (15). These observations suggest
that translational control ofa-actin synthesis is possible
under physiological conditions.
Translational control ofthe synthesis ofmuscle specific
proteins has also beennoted in other systems. Inthe ab-
sence ofCa2", rat muscle cells fail to synthesize muscle-
specific proteins in spite of the presence ofappropriate
mRNAs (17), but Ca2"-deprived avian or calf skeletal
muscle myoblasts accumulate normal levels of muscle-
specific proteins (17-21).
BC3H1 cells arrested in Gld show decreased rates of
synthesis ofP and y-actin relative to growing cells (5,6),
and the addition of FGF to such cells does not increase
the rate ofP and y actin synthesis (6). Infact, the rate of
pand y actin synthesis in FGF-treated cells continues to
decrease atthe same rate as indifferentiatingcellswhich
Ihble 1. Control of synthesis ofmuscle proteins by mitogens.a
Hour after
addition Rate of a-actin
of mitogen synthesis, %
Relative level of
a-actin mRNA, %
remaininGId(6)(Fig. 1). Additionofserumto cellsinGld
does result, as expected, in arapidincrease inthe rate of
synthesis ofPandy actins. However, as discussedinWice
et al. (6), factors in serum affect the rate of synthesis of
these proteins independent ofposition in the cell cycle.
Removal ofFGF fromthe mediaofcells arrested inGlq
allowsthe cellstoreturn toGldwithoutgoingthroughthe
full cell cycle (9). Thus, transitfromGld to Glq is fully re-
versible, and, at least for these cells, induction of the
differentiation program does not require aterminal cycle
of DNA synthesis (22).
Intracellular Signals that Control
Differentiation of BC3H1 Cells
The receptor for a number of mitogenic polypeptides
are tyrosine-specific proteinkinases, andthe FGF recep-
tor appears to fall into this category as well (23). Ib as-
sesswhetherthephosphorylation ofproteins ontyrosine
residueswas importantforthe control ofcell differentia-
tion, we examined the effects ofvanadate, aninhibitor of
tyrosine-specific proteinphosphatases (24-27) on differen-
tiated BC3H1 cells. The effects ofvanadate on cells are
complex and results obtained with this compound can
only be suggestive but not conclusive ofan involvement
oftyrosinephosphorylation (6). The experimental obser-
'~~~~~~ 1 'XWX :~~~~CP
Relative level of
M-CPK mRNA, %
0 100 100 100
4 86 - 80
8 71 127 55
12 29 - 40
24 29 105 -
aThe table summarizes dataona-actin synthesis fromWice, Milbrandt,
and Glaser(6)and ofM-CPK synthesis from Spizz et al. (10). Note that
after addition ofFGF to differentiated BC3H1 cells the rate ofa-actin
synthesis, measured byincorporation of35S-methionine, decreaseswhile
no corresponding decrease occurs in the level of a-actin mRNA meas-
uredby Northern analyses. Conversely, addition ofsenum to BC3H1 cells
results in asteady decline ofthe mRNAforM-CPK. This decline in M-
CPKmRNAfully accounts for the decrease in the rate ofM-CPK syn-
thesis in these cells [compare (4) and (10)].
FIGURE 3. Northern analysis ofM-CPK and actinmRNAlevels. BC3H1
cells wereplated in 150-mmtissue culture dishes(1.1 x 106cells/dish)
andwere switchedto DMEMcontaining 1% FCS 48hrlater(day0).
Ibtal cellular RNA was prepared on day 3 or 4 as indicated. Some
dishes received 20% FCS, FGF, or vanadate (VAN) for the final 24
hr. The a- andP- plus y-actin mRNAs are 1500 and 2100nucleotides
inlength, respectively. CPKmRNA is v1500 nucleotides in length.
Each lane represent 6 ,ug oftotal cell RNA. Reprinted in part with
permission (6).
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vations are thatvanadate fully mimics the action ofFGF
on BC3H1 cells and blocks their differentiation program
(6) (Figs. 1 and 3). By inference, we conclude that FGF
reverses the differentiation program by activation of
tyrosine-specific protein kinase of its receptor and that
this activation is sufficient to result in movement ofcells
from Gld toGlq. It seems unlikelythatP-TGF, which also
inhibits BC3H1 cell differentiation (13), initially uses the
same pathway as FGF, since activation oftyrosine kinases
byP-TGF have notbeenreported. Multiplepathways may
exist forthe control ofmyogenic differentiation which ul-
timately must come together and affect afew or one cen-
tral target molecule.
We do not know the targets ofthis tyrosine kinase and
canonly speculate onthe nature ofthe molecules involved
inthe repression ofthemuscle phenotype in BC3H1 cells.
Some of this speculation is by analogy to other muscle
cells studiedin anumberoflaboratories andimplicitly as-
sume that the fundamental processes that control mus-
cle differentiation will be the same in all cells.
When FGF is addedto BC3H1 cells, the cells movefrom
Gld to Glq, and we estimate that this represents a move-
ment ofthe cells about 4 to 6 hr closer to the G1-S bound-
ary in the cell cycle. We can then ask at which time does
repression or dedifferentiation take place. Does it follow
immediately upon addition ofmitogen, does it require 4
or5 hrofexposure to the mitogen, or does itrequire even
longer exposure to themitogen? Important asthese ques-
tions are, precise answers have not been forthcoming in
part because oftechnical problems associated with mea-
suring small changes overlarge backgrounds and in part
because most investigators have been interested in the
end point of the experiment rather than the kinetics.
Experiments in which the rate ofa-actin synthesis was
measured after addition of FGF to cells could be inter-
preted to indicate thatrepression occurs without signifi-
cant lag (2 hr) (6), but the complexity of the system re-
quires that this interpretation be made with caution.
Maximum repression ofactin synthesis requires up to 12
hrofexposure to FGF and occursinthe absence ofalarge
decrease in a-actin mRNA levels (6). Typical results are
presentedinTable 1. Ifthese data are taken atface value,
the intracellular signal responsible for repression of
a-actin synthesis is generated rapidly after addition of
FGF and before the cells reach Glq.
The decrease inthe rate ofsynthesis ofM-CPKfollow-
ing addition ofFGF to BC3H1 cells also occurs without
a significantlag(9). Measurements ofthe level ofM-CPK
mRNA in BC3H1 cells following addition of FGF again
indicates verylittle, ifany, lag in the decay ofthe level of
this mRNA, which is dependent on new protein synthe-
sis(10). These results suggest thatthe mitogenic polypep-
tide, FGF, induces the synthesis of one or more proteins
that repress the muscle-specific differentiation program
of BC3H1 cells.
FGF treatment ofquiescent 3T3 fibroblasts results in
their reentering and progressing through the cell cycle.
Concomitantly, these cellstransiently express several pro-
tooncogenes such as c-fos and c-myc in a sequential fash-
ion (28,29), suggesting that these gene products are im-
portant for movement from Go into G1. It is therefore
interesting to speculate that these gene products are in-
volved in the inhibition ofthe muscle-specific phenotype
since quiescent, differentiated BC3H1 cells express these
proteins in a similar fashion following their treatment
with FGF or serum(6). Two laboratories (30,31) have ex-
amined the effect ofincreasinglevels ofc-myc expression
on myogenic differentiation. In one case (31), transfection
ofBC3H1 cellswiththe c-mycgenewas onlyable topar-
tially inhibit the expression ofthe muscle specific pheno-
type. Inthe second case(30), L6E9-B cells, whichwerebio-
chemically differentiated but nonfused (fusion was
blockedby chelating Ca2+ with EGTA), responded to se-
rum treatment by transiently expressing c-myc mRNA
and reentering the cell cycle. However, the levels of
muscle-specific mRNAs were notgreatly affected by this
treatment, even96hrafter serumaddition. Theseresults
suggestthat c-myc expression can, atbest, onlypartially
block the differentiation ofmuscle cells. Conversely, the
oncogenic forms ofN-ras and H-ras have been shown to
completely blockmyoblast differentiation (32). Transfec-
tion ofthe C-2 myoblast cellline withthe N-ras oncogene
under the control of a steroid-inducible promoter only
blocked cellular differentiation when the cells are in-
cubated with dexamethasone (33).
Can we conclude from these experiments that the ex-
pression of c-ras following addition of mitogen controls
muscle differentiation? The answer is no. Induction of
c-ras by mitogens (when observed) is a relatively late
event after mitogen addition to cells (> 8 hr) (34). How-
ever, repression ofthe expression ofmuscle-specific pro-
teins is initiated within 1 and maximally 2 hr after addi-
tion of mitogen to cells. Moreover, transfection of
myoblasts with c-ras did not repress the muscle pheno-
type (32). Additionally, c-ras expression usually changes
very little, ifat all, as afunction ofposition in the cell cy-
cle (28).
In order to show that c-ras directly participates in the
repression ofmuscle-specific differentiation, it would be
necessary to demonstrate that the inhibition ofc-ras ex-
pressionblocks mitogen-induced repressionofthemuscle-
specific phenotype. This couldbe accomplishedby micro-
injecting antibodies directed against c-ras into differenti-
ated BC3H1 cells. Such experiments have been success-
fully used to inhibit the NGF-induced differentiation of
PC12 cells(35)andthe serum-inducedgrowthofquiescent
3T3 cells (36). Alternatively, antisense oligonucleoside
methylphosphonates (oligo MP) (37) could potentially
block the expression of endogenous c-ras by preventing
the synthesis ofnew c-ras protein. Ideally, an antisense
oligo(MP)directedagainstthe5' capregionofthemRNA
wouldhavethegreatest chance ofcompletelyblockingthe
translation ofc-ras mRNA(38). However, evenifthese ex-
periments confirm that by blocking c-ras activity you
were able toprevent FGF-inducedrepressionofthe mus-
clephenotype, itwouldnotbepossible to determine ifthis
correlation was casual or causal. For example, blocking
ras expression mightprevent movement fromGld to Glq
and might not be directly involved as a repressor ofthe
muscle phenotype. Clearly, additional experiments using
146CONTROL OF DIFFERENTIATION OF BC3H1 MUSCLE CELLS 147
different approaches to the problem will be required.
One powerful technique for potentially identifying a
muscle-specific repressor is reverse genetics. However,
this technique has metwithmixed success. Forexample,
growth-related genes are identified by screeningfor cog-
nate RNAs whose levels are increased following serum
orgrowth factor stimulation ofquiescent cells. However,
this approach has identified a human ADP/ATP translo-
case (39) andactin(40) as agrowth-regulated gene. Other
experiments have demonstrated that actin synthesis in-
creasesfollowing serum stimulation ofquiescent cells(40).
Although these RNAs are certainly expressed at differ-
entlevels inquiescent andmitogen-stimulated cells, their
role as regulatory proteins would seem to be doubtful at
best. Therefore, inordertoidentify FGF-induced muscle
specific repressor proteins, a more restrictive screening
protocol will have tobe devised. Forexample, thisrepres-
sor(s) should be expressed in BC3H1 cellsthat are inGlq
and also in quiescent C2 cells that are expressing H-ras.
Since quiescent, differentiated BC3H1 or C2 cells should
not be expressing this repressor(s), a plus/minus DNA
screening with RNA derived from these different cells
and cell conditions might be useful in identifying this
repressor(s).
The regulation ofthe expression ofmuscle-specific pro-
teins is complex, at least four different control mecha-
nisms have been identified (17): transcriptional control,
differential splicing of certain gene products associated
with differentiation process, translational control, which
inrat cells canbe controlledbyCa2+ levels(lowCa2+ pre-
vents translation of muscle-specific mRNA), but which
does not apply to avian cells where muscle-specific pro-
teins are synthesized in low Ca2+ media in the absence
offusion andfinally mRNA stability. Mitogens havebeen
shown to influence at least two ofthese regulator steps
oftranscriptional andtranslational control andmayaffect
all ofthem(4,6,9,10,13). Itis not clear, however, whether
these fourpoints ofregulation canbe controlled indepen-
dently by mitogens or whether control is coordinate un-
der all circumstances.
Myoblasts, unlike BC3H1 cells, fuse and irreversibly
withdrawfrom the cell cycle and simultaneously become
refractory to the repression by mitogens, but we do not
understand the molecular basis of this phenomenon.
Several laboratories have suggested thatmitogens cease
to be effectors because the cells lose mitogen receptors.
This is an attractive idea but one forwhich the evidence
is conflicting. For example, in L6E9 cells induction of
c-myc by mitogens can occur in differentiated cells, sug-
gesting the presence of mitogenic receptors (30). Simi-
larly, the ability ofP-transforminggrowth factor(j3-TGF)
to blockmyoblast differentiation is not due to the disap-
pearance ofP-TGF receptors fromthese cells(41). By con-
trast, experiments with C-2 muscle cells suggest thatfu-
sion but not withdrawal from the cell cycle and
differentiation results in downregulation of P-TGF and
EGF receptors (41). Clearly the cause of the unrespon-
siveness ofmyotubes to mitogenic signals remains to be
established.
While the intracellular signals that control differentia-
tion either in BC3H1 or other muscle cells remain to be
established, the importance for stem cellsto have achoice
ofquiescent states that are eitherpermissive ornonper-
missive for differentiation is the most important conclu-
sion to be drawn from experiments with BC3H1 cells. In
the context ofa complex multicellular organism, muscle
or other cells mustbe able to become quiescent with and
withoutbecomingdifferentiated. For severalyearsmany
investigators have noted that some cells respond to
specificmitogenicpolypeptides bypartial transitthrough
G1 portion ofthe cell cycle andhave designated such mito-
gens as competence factors versus progression factors
that allow cells to continue through the cell cycle (43-45).
We hypothesize that competence factors in general
serve the function ascribed to FGF for BC3H1 cells, they
control the movement of cells between Gld and Glq and
therefore allow differentiation and quiescence to be un-
coupled.
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